Silveus Ins_4-21-09Miller BrangusRed Angus Assn
Advertise With Us Subscribe Today Facebook
SouthernLivestock.com
Not a member? Membership has its privileges— Register today! • Make SLS your homepage!
home articles New Products | Email to a Friend

DRAXXIN(r) and EXCEDE(r) Receive FDA Approval to Treat Foot Rot

published: November 4th 2008
source: Pfizer Animal Health

NEW YORK (Nov. 4, 2008) - Cattle producers can now treat foot rot with the most convenient, single-dose anti-infectives on the market-DRAXXIN(r) (tulathromycin) Injectable Solution and EXCEDE(r) (ceftiofur crystalline free acid) Sterile Suspension. In addition to treating bovine respiratory disease (BRD), DRAXXIN and EXCEDE are approved to effectively treat foot rot in cattle.
    Foot rot is a common cause of cattle lameness that can affect 10 to 15 percent of a herd.1 According to Gordon Brumbaugh, DVM, PhD, DACVIM, DACVCP, anti-infectives specialist with Pfizer Animal Health, along with management techniques like clean and dry bedding and pens, foot rot management typically includes treating affected cattle with anti-infectives such as DRAXXIN or EXCEDE.
    "A single dose of DRAXXIN or EXCEDE works along with a cattle's immune system to treat disease without repeated administration," said Brumbaugh, "which gives producers flexibility and the ability to make management adjustments based on labor or market factors."
    DRAXXIN is also approved for the treatment and control of BRD, or calf pneumonia, in high-risk cattle; and it is the only product that treats and controls BRD caused by all four major BRD pathogens-including     Mycoplasma bovis. DRAXXIN also treats pink eye associated with Moraxella bovis in beef cattle.
DRAXXIN is not for use in female dairy cattle 20 months of age or older or in calves to be processed for veal. DRAXXIN has a pre-slaughter withdrawal time of 18 days.  Visit draxxin.com <http://www.draxxin.com>  for full prescribing information.
    EXCEDE is the only antibiotic to deliver 7 days of antibiotic therapy with a single dose for the effective control and treatment of BRD associated with Mannheimia haemolytica, Pastuerella multocida and
Histophilus somni in high-risk animals. EXCEDE can be administered at the base of ear for convenience or middle one-third of ear to promote better beef quality.
    As with all drugs, the use of EXCEDE Sterile Suspension is contraindicated in animals previously found to be hypersensitive to the drug. Though safe in cattle when properly administered, inadvertent
intra-arterial injection in the ear is possible and is fatal. EXCEDE has a pre-slaughter withdrawal time of 13 days.
    Visit excede.com <http://www.excede.com>  for full prescribing information.
 

Site:   Home   Publications   Market Reports   Sale Reports   Sale Calendar   Classifieds   Cattle & Service Directory   Full Commodities Report   Services   About Us   Contact Us

Article Categories:   All   Industry News   Herd Health   Feed & Nutrition   Pastures & Forages   Reproduction   Marketing   Columnists   Production   Genetics & Performance   Weather Forecast   Breed News   Producer Feature Stories   Items of Interest   New Products   Recipes

User:   Login   Logout   Register/Profile   Submit Market Report   Submit Sale Report